Lumera, Merging With GigOptix, Will Shutter Plexera, Sell Off Protein Array Tech, IP

As recently as February, Plexera was touting the Kx5 as a replacement for the internally developed protein-array platforms commonly used in pharmaceutical R&D. However, according to company officials, the funding necessary to push the system into the market just wasn’t there.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.